SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine High dose
Sponsors
AIM Vaccine Co., Ltd.
Conditions
SARS-CoV-2
Unknown Phase
A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China
NCT05550142
Start: 2022-09-16End: 2024-03-31Updated: 2023-02-14
A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People
NCT05549206
Start: 2023-04-30End: 2024-04-30Target: 350Updated: 2023-03-16